Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Islam Y Elgendy

Showing results (1-10 of 448) with videos related to

Pageof 45
Sort By:
Annals of Internal Medicine|September 14, 2020
In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortalityIslam Y Elgendy
Annals of Internal Medicine|September 14, 2020
In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleedingIslam Y Elgendy
Annals of Internal Medicine|May 5, 2025
In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 moHend Mansoor, Islam Y Elgendy,
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
Sex-Specific Coronary Artery Calcium Score Thresholds Predictive of Obstructive Coronary Artery Disease: Ready for Prime Time?Khansa Ahmad, Islam Y Elgendy
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 5, 2021
Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleteriousIslam Y Elgendy, Hani Jneid
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Transcatheter Closure of Postinfarct Ventricular Septal Defect: Promises and UncertaintiesAravdeep Jhand, Islam Y Elgendy
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Annals of Internal Medicine|December 1, 2025
In adults with MI and LVEF >40% after invasive care, β-blocker therapy did not reduce a composite adverse outcome at a median 3.7 yOrly Leiva, Islam Y Elgendy,
Revista Espanola De Cardiologia (English Ed.)|January 18, 2022
Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trialMohamed Hamza, Islam Y Elgendy
Journal of the Society for Cardiovascular Angiography & Interventions|September 11, 2025
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: A New Management Paradigm?Aravdeep Jhand, Islam Y Elgendy
Pageof 45

Showing results (1-10 of 448) with videos related to

Sort By:
Pageof 45
Annals of Internal Medicine|September 14, 2020
In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortalityIslam Y Elgendy
Annals of Internal Medicine|September 14, 2020
In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleedingIslam Y Elgendy
Annals of Internal Medicine|May 5, 2025
In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 moHend Mansoor, Islam Y Elgendy,
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
Sex-Specific Coronary Artery Calcium Score Thresholds Predictive of Obstructive Coronary Artery Disease: Ready for Prime Time?Khansa Ahmad, Islam Y Elgendy
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 5, 2021
Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleteriousIslam Y Elgendy, Hani Jneid
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Transcatheter Closure of Postinfarct Ventricular Septal Defect: Promises and UncertaintiesAravdeep Jhand, Islam Y Elgendy
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Annals of Internal Medicine|December 1, 2025
In adults with MI and LVEF >40% after invasive care, β-blocker therapy did not reduce a composite adverse outcome at a median 3.7 yOrly Leiva, Islam Y Elgendy,
Revista Espanola De Cardiologia (English Ed.)|January 18, 2022
Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trialMohamed Hamza, Islam Y Elgendy
Journal of the Society for Cardiovascular Angiography & Interventions|September 11, 2025
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: A New Management Paradigm?Aravdeep Jhand, Islam Y Elgendy
Pageof 45